Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nexalin Technology Inc. (NXL:NASDAQ), powered by AI.
Nexalin Technology Inc. is currently trading at $0.39. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Nexalin Technology Inc. on Alpha Lenz.
View Nexalin Technology Inc.'s valuation metrics on Alpha Lenz.
“Nexalin Technology Inc.'s ROE is -221.5%. Explore profitability and growth together.”
Ask for details →Nexalin Technology Inc. is a pioneering company in the medical technology sector, specializing in the development of innovative solutions for the treatment of mental health disorders. Its primary focus lies in non-invasive neurostimulation devices designed to help alleviate symptoms of conditions such as anxiety, depression, and insomnia. Utilizing a cutting-edge approach known as transcranial electrical stimulation, Nexalin aims to provide an alternative to pharmaceutical treatments, thereby addressing the growing demand for safer and more effective mental health care options. Nexalin Technology Inc. is significant within the healthcare industry, as it holds the potential to revolutionize the treatment landscape for mental health by offering novel, efficient, and patient-friendly solutions. By aligning with global trends emphasizing mental health awareness and treatment accessibility, the company plays a crucial role in supporting and shaping the future of mental healthcare provision. As the industry evolves, Nexalin continues to explore and expand its technological capabilities, contributing to the overall advancement of medical devices aimed at enhancing mental wellness.
“Nexalin Technology Inc.'s ROE is -221.5%. Explore profitability and growth together.”
Ask for details →Nexalin Technology Inc. (ticker: NXL) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 6 employees.
The current price is $0.393 with a P/E ratio of -x and P/B of -x.
ROE is -221.50% and operating margin is -2781.69%. Annual revenue is $301,647.